Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
Clinical trial NCT01873326 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01873326
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.